This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lamb Weston (LW) Q4 Earnings Lag Estimates, Sales Down Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2020 sales decline due to lower demand in the Foodservice and Global segment amid the coronavirus outbreak.
Will Tyson Foods' (TSN) Q3 Earnings Reflect Coronavirus Woes?
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter results are likely to reflect soft foodservice volumes and elevated cost of production due to the coronavirus pandemic.
Things You Must Know Ahead of AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
Softness in the on-premise channel due to closure of restaurants and bars is expected to have marred AB InBev's (BUD) top line in Q2. E-commerce sales are likely to partly cushion results.
Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings
by Zacks Equity Research
Retail store closures and supply chain disruptions might show on Newell's (NWL) second-quarter 2020 results.
Is Colgate (CL) Poised to Beat Earnings Estimates in Q2?
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 sales are likely to have benefited from investment in brands, favorable pricing strategy, innovative product launches and enhancement of e-commerce capabilities.
How is Keurig Dr Pepper (KDP) Placed Ahead of Q2 Earnings?
by Zacks Equity Research
Higher adjusted operating margin, a lower effective tax rate and reduced interest expenses might show on Keurig Dr Pepper's (KDP) bottom line in second-quarter 2020.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Impact Pilgrim's Pride's (PPC) Q2 Earnings
by Zacks Equity Research
Macroeconomic headwinds in Mexico and high input costs are likely to get reflected in Pilgrim's Pride's (PPC) Q2 performance. Nevertheless, strength in Prepared Foods unit bodes well.
Here's How Kraft Heinz (KHC) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Increased demand owing to higher at-home consumption amid the coronavirus outbreak is likely to get reflected in Kraft Heinz's (KHC) second-quarter 2020 performance.
Kellogg (K) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Kellogg's (K) second-quarter results are likely to reflect high demand amid pandemic-led increased at-home consumption. However, adverse impacts of divestitures and currency volatility are concerns.
Here's How B&G Foods (BGS) Looks Just Ahead of Q2 Earnings
by Zacks Equity Research
B&G Foods' (BGS) second-quarter results are likely to reflect higher demand amid coronavirus-led increased at-home consumption. Also, the company's pricing strategy and saving efforts bode well.
Things to Note Ahead of Procter & Gamble's (PG) Q4 Earnings
by Zacks Equity Research
Strong demand for Procter & Gamble's (PG) products, which are deemed essential, is likely to have aided performance in fiscal fourth quarter.
Soft On-Premise Sales to Mar Molson Coors' (TAP) Q2 Earnings
by Zacks Equity Research
Molson Coors' (TAP) second-quarter 2020 results are likely to reflect significant impacts from the closure of on-premise sales channels in almost all markets and other headwinds on the global economy.
Boston Beer (SAM) Stock Up on Q2 Earnings Beat, Sales Up Y/Y
by Zacks Equity Research
Boston Beer's (SAM) Q2 results gain from solid depletion growth along with strength in Truly Hard Seltzer and Twisted Tea as well as the Dogfish Head brands.
Factors Likely to Decide Archer Daniels' (ADM) Q2 Earnings
by Zacks Equity Research
Soft results across the Carbohydrate Solutions, and Ag Services and Oilseeds segments might show on Archer Daniels' (ADM) second-quarter 2020 results.
Clorox (CLX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Soap & Cleaning Materials Industry Outlook Bubbling With Optimism
by Rajani Lohia
Escalated demand for hand sanitizers, toilet paper, surface cleaners, disinfecting wipes and other household cleansing essentials are likely to aid Soap & Cleaning Materials players in the near term.
Kimberly-Clark (KMB) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) generates robust cost savings in second-quarter 2020. Also, the company witnesses strong demand in the Consumer Tissue segment amid the coronavirus outbreak.
Clorox (CLX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $227.55, moving +0.36% from the previous trading session.
Here's How Mondelez (MDLZ) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Impacts of higher customer service, labor and logistics costs are likely to get reflected in Mondelez's (MDLZ) second-quarter 2020 performance.
3 Reasons Why Growth Investors Shouldn't Overlook Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) could produce exceptional returns because of its solid growth attributes.
Here's How Kimberly-Clark (KMB) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Increased demand owing to consumer stockpiling trends amid the coronavirus outbreak is likely to get reflected in Kimberly-Clark's (KMB) second-quarter 2020 performance.
Factors to Decide the Fate of Coca-Cola (KO) in Q2 Earnings
by Zacks Equity Research
Coca-Cola's (KO) Q2 results are likely to reflect the impacts of declines in away-from-home channels and adverse currency. Growth in e-commerce is likely to have party cushioned its performance.
The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg
Boston Beer (SAM) to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are likely to reflect continued gains from strength in depletions and shipments. Soft on-premise demand and higher costs are expected to have marred its performance.